View in EDS

Assessment of Guideline-Nonconcordant Radiotherapy in Medicare Beneficiaries With Metastatic Cancer Near the End of Life, 2015-2017.

Saved in:
Bibliographic Details
Title: Assessment of Guideline-Nonconcordant Radiotherapy in Medicare Beneficiaries With Metastatic Cancer Near the End of Life, 2015-2017.
Authors: Santos PMG; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Mathis NJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Lapen K; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Lobaugh S; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Yerramilli D; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Bekelman JE; Department of Radiation Oncology, Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia., Gillespie EF; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, New York.
Source: JAMA health forum [JAMA Health Forum] 2022 Jan 14; Vol. 3 (1), pp. e214468. Date of Electronic Publication: 2022 Jan 14 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101769500 Publication Model: eCollection Cited Medium: Internet ISSN: 2689-0186 (Electronic) Linking ISSN: 26890186 NLM ISO Abbreviation: JAMA Health Forum
Database: MEDLINE Ultimate
Description
ISSN:2689-0186
DOI:10.1001/jamahealthforum.2021.4468